Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines (Q34471352)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines |
scientific article |
Statements
1 reference
Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines (English)
1 reference
Bell IM
1 reference
Erb JM
1 reference
Freidinger RM
1 reference
Gallicchio SN
1 reference
Guare JP
1 reference
Guidotti MT
1 reference
Halpin RA
1 reference
Hobbs DW
1 reference
Homnick CF
1 reference
Kuo MS
1 reference
Lis EV
1 reference
Mathre DJ
1 reference
Michelson SR
1 reference
Pawluczyk JM
1 reference
Pettibone DJ
1 reference
Reiss DR
1 reference
Vickers S
1 reference
Williams PD
1 reference
Woyden CJ
1 reference
1 June 1998
1 reference
1 reference
41
1 reference
12
1 reference
2146-2163
1 reference
Identifiers
1 reference
1 reference